Position in AZN
as of Mar 31, 2026
· filed May 14, 2026
Position Value
$300,142,412
New position
Shares Held
1,521,866
first reported quarter
Ownership
0.098%
of shares outstanding
% of Portfolio
0.56%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2026
1 quarter on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Position in Drug Manufacturers - General
Healthcare · as of Mar 31, 2026CANADA LIFE ASSURANCE Co holds $2,873,352,929 across 9 Drug Manufacturers - General names. AZN ranks #5 (10.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
|
2,567,817 | $627,677,187 | |
| 2 | LLY |
ELI LILLY & Co
|
630,459 | $579,877,274 | |
| 3 | ABBV |
AbbVie Inc.
|
1,742,412 | $378,957,185 | |
| 4 | MRK |
Merck & Co., Inc.
|
2,974,102 | $357,754,728 | |
| 5 | AZN |
Astrazeneca PLC
This page
|
1,521,866 | $300,142,412 | |
| 6 | GILD |
Gilead Sciences, Inc.
|
1,675,983 | $233,581,750 | |
| 7 | PFE |
Pfizer Inc
|
6,657,890 | $186,953,551 | |
| 8 | BMY |
Bristol Myers Squibb Co
|
3,068,316 | $186,093,365 |
All Filings in AZN
Export CSV
1 filing row on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $300,142,412 | 1,521,866 | Shares | Sole | 2026-05-14 | |
| No filing history on record for this holder in this stock. | ||||||